Cure Gm1 Incorporated
Cure Gm1 Incorporated's latest filing in the PeerBasis snapshot reports a Part VII D + F figure of $896 for Christine M Waggoner, Ceo (FY 2024). Column F can include amounts from the filing and related organizations.
After indexing supported filing years to 2025 comparison dollars, the subject figure is $920. It is higher than the D + F figure for 0 of 22 peer organizations selected under the disclosed tier Same NTEE sector (H12), nationwide + size band 0.67–1.5× revenue (approximately 0%; median $71,895). This is descriptive, not a reasonableness conclusion.
Preparing executive-pay materials for this board?
Review the selected comparables for Cure Gm1 Incorporated, then prepare a source-linked report and bracketed documentation worksheet for the board to verify and complete.
Review the peer setSelected peer organizations
Actual selection tier: Same NTEE sector (H12), nationwide + size band 0.67–1.5× revenue. Displayed D + F figures from supported filing years are indexed to 2025 comparison dollars with BLS CPI-U; a nationwide tier also uses 2024 BEA RPP as a consumer price-level proxy when both the subject and peer have supported state codes. Unsupported state codes receive no interstate adjustment. Comparison values can differ from the raw filing. Column F may include related-organization amounts.
| Organization | State | Revenue | D + F (2025 dollars) |
|---|---|---|---|
| Reed Gastrointestinal Oncology Research | AL | $343,393 | $95,957 |
| Solving Kids' Cancer Inc | NY | $333,401 | $165,331 |
| Asbestos Disease Awareness Organization Inc | CA | $332,179 | $123,158 |
| Childrens Skin Disease Foundation | CA | $331,103 | $56,412 |
| New England Parkinsons Ride | NH | $330,154 | $118,301 |
| The Norma Livingston Ovarian Cancer | AL | $325,026 | $101,874 |
| The Cute Syndrome Foundation | MO | $365,290 | $93,843 |
| Team Bright Side Inc | IL | $366,034 | $28,403 |
View the organization record and available filings on ProPublica